running-list-of-issues-re-using-pcr-testing-for-covid-19

Running List of Issues Re: Using PCR Testing for COVID-19


Here is a running list of evidence showing that there have been serious issues with using PCR testing (polymerase chain reaction) for detecting COVID-19.





https://www.cdc.gov/csels/dls/locs/2021/07-21-2021-lab-alert-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html


Link to Scott Wilk’s tweet.


Fauci says that anything about a cycle threshold of 35 is just dead virus particles.


LINK TO TWEET / LINK TO ARTICLE IN CYPRUS MAIL


LINK TO TWEET / LINK TO BELOW TWEET


https://www.fda.gov/media/134922/download

“The analytical sensitivity of the rRT-PCR assays contained in the CDC 2019 Novel Coronavirus (2019-
nCoV) Real-Time RT-PCR Diagnostic Panel were determined in Limit of Detection studies. Since no
quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed
and this study conducted, assays designed for detection of the 2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full length RNA
(N gene; GenBank accession: MN908947.2) of known titer (RNA copies/µL) spiked into a diluent consisting of a suspension of human A549 cells and viral transport medium (VTM) to mimic clinical specimen. Samples were extracted using the QIAGEN EZ1 Advanced XL instrument and EZ1 DSP Virus Kit (Cat# 62724) and manually with the QIAGEN DSP Viral RNA Mini Kit (Cat# 61904). Real-Time RT-PCR assays were performed using the Thermo Fisher Scientific TaqPath™ 1-Step RT-qPCR Master Mix, CG (Cat# A15299) on the Applied Biosystems™ 7500 Fast Dx RealTime PCR Instrument according to the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel instructions for use.”


Feature image: Senado Federal

(Visited 1 times, 1 visits today)

Accessibility Toolbar